Lysis of allogeneic human lymphocytes by nonspecifically activated T-like cells

A. J. McMichael, F. M. Gotch, James Hildreth

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In the generation of cytotoxic effector cells specific for influenza A virus-infected lymphocytes, 3 donors have given an unusual pattern of lytic activity, killing HLA-mismatched target cells. This has been analyzed in detail for 1 donor and 1 of the other 2 shows similar results. Activation only requires culture in medium between 1 and 4 days and parallels development of cell line K562-directed natural killer cells. Target lymphocytes do not need to be virus-infected and appear to be normal lymphocytes. The effector cells carry the surface markers T3 and T8 defined by OKT3/anti-Leu4 and OKT8/anti-Leu2a monoclonal antibodies, respectively. Unlike HLA class 1-restricted or -directed cytotoxic T cells, neither anti-Leu2a nor anti-Leu4 blocked killing in the absence of complement. MHM23, a monoclonal antibody specific for the human lymphocyte function antigen, blocked lysis. The results indicate that these effector cells are related to cytotoxic T lymphocytes, but can lyse allogeneic target cells through a different recognition process. There is some specificity because autologous cells were not killed.

Original languageEnglish (US)
Pages (from-to)1002-1005
Number of pages4
JournalEuropean Journal of Immunology
Volume12
Issue number12
StatePublished - 1982
Externally publishedYes

Fingerprint

Lymphocytes
Monoclonal Antibodies
Muromonab-CD3
Influenza A virus
Cytotoxic T-Lymphocytes
Natural Killer Cells
Culture Media
Viruses
T-Lymphocytes
Antigens
Cell Line

ASJC Scopus subject areas

  • Immunology

Cite this

Lysis of allogeneic human lymphocytes by nonspecifically activated T-like cells. / McMichael, A. J.; Gotch, F. M.; Hildreth, James.

In: European Journal of Immunology, Vol. 12, No. 12, 1982, p. 1002-1005.

Research output: Contribution to journalArticle

@article{c46d2ece35164218adc2556ce4a23002,
title = "Lysis of allogeneic human lymphocytes by nonspecifically activated T-like cells",
abstract = "In the generation of cytotoxic effector cells specific for influenza A virus-infected lymphocytes, 3 donors have given an unusual pattern of lytic activity, killing HLA-mismatched target cells. This has been analyzed in detail for 1 donor and 1 of the other 2 shows similar results. Activation only requires culture in medium between 1 and 4 days and parallels development of cell line K562-directed natural killer cells. Target lymphocytes do not need to be virus-infected and appear to be normal lymphocytes. The effector cells carry the surface markers T3 and T8 defined by OKT3/anti-Leu4 and OKT8/anti-Leu2a monoclonal antibodies, respectively. Unlike HLA class 1-restricted or -directed cytotoxic T cells, neither anti-Leu2a nor anti-Leu4 blocked killing in the absence of complement. MHM23, a monoclonal antibody specific for the human lymphocyte function antigen, blocked lysis. The results indicate that these effector cells are related to cytotoxic T lymphocytes, but can lyse allogeneic target cells through a different recognition process. There is some specificity because autologous cells were not killed.",
author = "McMichael, {A. J.} and Gotch, {F. M.} and James Hildreth",
year = "1982",
language = "English (US)",
volume = "12",
pages = "1002--1005",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "12",

}

TY - JOUR

T1 - Lysis of allogeneic human lymphocytes by nonspecifically activated T-like cells

AU - McMichael, A. J.

AU - Gotch, F. M.

AU - Hildreth, James

PY - 1982

Y1 - 1982

N2 - In the generation of cytotoxic effector cells specific for influenza A virus-infected lymphocytes, 3 donors have given an unusual pattern of lytic activity, killing HLA-mismatched target cells. This has been analyzed in detail for 1 donor and 1 of the other 2 shows similar results. Activation only requires culture in medium between 1 and 4 days and parallels development of cell line K562-directed natural killer cells. Target lymphocytes do not need to be virus-infected and appear to be normal lymphocytes. The effector cells carry the surface markers T3 and T8 defined by OKT3/anti-Leu4 and OKT8/anti-Leu2a monoclonal antibodies, respectively. Unlike HLA class 1-restricted or -directed cytotoxic T cells, neither anti-Leu2a nor anti-Leu4 blocked killing in the absence of complement. MHM23, a monoclonal antibody specific for the human lymphocyte function antigen, blocked lysis. The results indicate that these effector cells are related to cytotoxic T lymphocytes, but can lyse allogeneic target cells through a different recognition process. There is some specificity because autologous cells were not killed.

AB - In the generation of cytotoxic effector cells specific for influenza A virus-infected lymphocytes, 3 donors have given an unusual pattern of lytic activity, killing HLA-mismatched target cells. This has been analyzed in detail for 1 donor and 1 of the other 2 shows similar results. Activation only requires culture in medium between 1 and 4 days and parallels development of cell line K562-directed natural killer cells. Target lymphocytes do not need to be virus-infected and appear to be normal lymphocytes. The effector cells carry the surface markers T3 and T8 defined by OKT3/anti-Leu4 and OKT8/anti-Leu2a monoclonal antibodies, respectively. Unlike HLA class 1-restricted or -directed cytotoxic T cells, neither anti-Leu2a nor anti-Leu4 blocked killing in the absence of complement. MHM23, a monoclonal antibody specific for the human lymphocyte function antigen, blocked lysis. The results indicate that these effector cells are related to cytotoxic T lymphocytes, but can lyse allogeneic target cells through a different recognition process. There is some specificity because autologous cells were not killed.

UR - http://www.scopus.com/inward/record.url?scp=0020359661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020359661&partnerID=8YFLogxK

M3 - Article

C2 - 6984389

AN - SCOPUS:0020359661

VL - 12

SP - 1002

EP - 1005

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 12

ER -